How many institutions held TIVC - Valion Bio, Inc. - Common Stock, par value $0.0001 per share in Q2 2025?

4 institutional investors reported TIVC - Valion Bio, Inc. - Common Stock, par value $0.0001 per share for Q2 2025. Use the holders table for investor-level position and value details.

Valion Bio, Inc. - Common Stock, par value $0.0001 per share (TIVC)

Q: What does CUSIP 888705308 represent in this 13F holders report?

CUSIP 888705308 is the security identifier for TIVC - Valion Bio, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 888705308

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 2,789,768
Total 13F shares: 44,961
Share change: +5,657
Total reported value: $186,587
Price per share: $4.14
Number of holders: 4
Value change: +$23,476
Number of buys: 2

Quarterly Holders Quick Answers

What is CUSIP 888705308?
CUSIP 888705308 identifies TIVC - Valion Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 888705308:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of TIVC - Valion Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SBI Securities Co., Ltd.	13F	Company	0%	16	$41	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	5	$13	—	31 Mar 2025	13F
John Claude	3/4/5	10%+ Owner	— class O/S missing	1,196,000	—	—	10 Nov 2021	3/4/5
Blake Gurfein	3/4/5	Chief Scientific Officer	— mixed-class rows	235,000 mixed-class rows	—	—	18 Dec 2024	3/4/5
Veronica Cai	3/4/5	Chief Financial Officer	— class O/S missing	117,880	—	—	01 Apr 2022	3/4/5
Briana Benz	3/4/5	Chief Financial Officer	— class O/S missing	112,500	—	—	10 Nov 2021	3/4/5
Ryan Sabia	3/4/5	Chief Operating Officer	— class O/S missing	100,000	—	—	08 May 2023	3/4/5
Kimberly Ann Bambach	3/4/5	Interim CFO	— class O/S missing	7,500	—	—	01 Oct 2024	3/4/5
Karen Drexler	3/4/5	Director	— class O/S missing	3,000	—	—	30 Sep 2024	3/4/5

Institutional Holders of Valion Bio, Inc. - Common Stock, par value $0.0001 per share (TIVC) as of Q2 2025

As of 30 Jun 2025, Valion Bio, Inc. - Common Stock, par value $0.0001 per share (TIVC) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,961 shares. The largest 4 holders included Marex Group plc, UBS Group AG, SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/. This page lists 4 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.